Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuroprotective effects of VCP modulators in mouse models of glaucoma.
Nakano N, Ikeda HO, Hasegawa T, Muraoka Y, Iwai S, Tsuruyama T, Nakano M, Fuchigami T, Shudo T, Kakizuka A, Yoshimura N. Nakano N, et al. Among authors: kakizuka a. Heliyon. 2016 Apr 19;2(4):e00096. doi: 10.1016/j.heliyon.2016.e00096. eCollection 2016 Apr. Heliyon. 2016. PMID: 27441270 Free PMC article.
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.
Ikeda HO, Muraoka Y, Hata M, Sumi E, Ikeda T, Nakagawa T, Abe H, Tada H, Morita S, Kakizuka A, Yoshimura N, Tsujikawa A. Ikeda HO, et al. Among authors: kakizuka a. PLoS One. 2020 Feb 13;15(2):e0229068. doi: 10.1371/journal.pone.0229068. eCollection 2020. PLoS One. 2020. PMID: 32053676 Free PMC article. Clinical Trial.
160 results